ABOUT POTENTIA
RESEARCH FOCUS
TECHNOLOGY
PRODUCTS
POT-4
COLLABORATIONS
FOR INVESTORS
Products

POT-4


Click image to view larger »
POT-4 is a derivative of the cyclic peptide Compstatin, discovered at the University of Pennsylvania. POT-4 is a peptide capable of binding to human complement factor C3 (C3) and prevent its activationm, resulting in broad and potent complement activation inhibition.

Potentia Pharmaceuticals, Inc. 201 E. Jefferson Street,
Suite 312, Louisville, KY 40202 | 502-569-1053
© 2006 Potentia, Inc.
All Rights Reserved. | Site by Acsys